GLOBAL GERD DRUGS AND DEVICES MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL GERD DRUGS AND DEVICES MARKET FORECAST 2018-2026

GLOBAL GERD DRUGS AND DEVICES MARKET FORECAST 2018-2026

The Global GERD Drug and devices market is anticipated to grow at a CAGR of 1.12% between 2019 and 2027. Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder. It is defined as the complications arising from the backflow of gastric contents into the esophagus due to weakened lower esophageal sphincter (LES). The following factors primarily drive the GERD Drug and devices market:

GLOBAL GERD DRUGS AND DEVICES MARKET FORECAST 2018-2026

Request free sample

The Global GERD Drug and devices market is anticipated to grow at a CAGR of 1.12% between 2019 and 2027. Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder. It is defined as the complications arising from the backflow of gastric contents into the esophagus due to weakened lower esophageal sphincter (LES). The following factors primarily drive the GERD Drug and devices market:

  • Growing trend of self-medication
  • Increasing awareness about GERD
  • Increasing occurrence of GERD disorders
  • Changes in lifestyle

The important drivers increasing growth in the global GERD Drug and devices Market are increasing awareness about GERD and Increasing occurrence of GERD disorders. Awareness among individuals about GERD and its complications is increasing nowadays. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade.

The Drugs and devices of GERD Drug and devices market are used extensively for various purposes. Antacids are preferred as first-line therapy for mild and infrequent symptoms as they immediately neutralize gastric acid secretions. The body well absorbs H2 receptor blockers and provide quick relief from the esophagus symptoms. Proton pump inhibitors inhibit gastric acid secretion by inhibition of the H+/K+ ATPase enzyme system in the gastric parietal cells. Pro-kinetic agents, also known as promobility agents, stimulate the muscles of the gastrointestinal tract and strengthen lower esophageal sphincter, thereby reducing acid reflux into the esophagus. Digitrapper reflux testing system observes & records the extra-esophageal symptoms of acid reflux. The Bravo System is a diagnostic system to determine the frequency & duration of acid reflux. MUSE is an endoscopic device used for transoral fundoplication. The Other devices are Endostim Neurostimulation System, EsophyX. Endostim Neurostimulation System is a system consists of Neurostimulator (IPG), implantable bipolar lead & wireless external programmer.

Patent Expiry and Adverse Effect of Proton Pump Inhibitors and Other Drugs are the major factors hindering the GERD Drug and devices market. In recent years, several drugs to treat GERD lost their patent protection in the U.S. and other countries worldwide. Every drug taken by patients for disease treatment has certain adverse effects.

The Global GERD Drug and devices market segments include Drugs and devices.

Drugs and devices are segmented into:

  • Drug class
    • Antacids
    • H2 receptor blockers
      • Cimetidine
      • Famotidine
      • Nizatidine
      • Ranitidine HCL
    • Proton pump inhibitors (PPI)
      • Nexium
      • Prilosec/ Losec
      • Aciphex/ Pariet
      • Dexilant
      • Protonix
      • Prevacid
      • Zegerid
      • Other generic PPI
    • Pro-kinetic agents
  • Devices
    • Digitrapper
    • Bravo system
    • Stretta
    • Linx reflux management system
    • Muse (medigus ultrasonic surgical endostapler) system
    • Other devices

This report covered the present market conditions and the growth prospects of the global GERD Drug and devices market for 2019-2027 and considered the revenue generated through the sales of GERD Drug and devices for Drugs and devices to calculate the market size by considering 2018 as the base year.

Geographically, the global GERD Drug and devices market has been segmented on the basis of four major regions, which include:

  • North America: The United States & Canada
  • Asia-Pacific: China, India, Japan, Australia, South Korea & Rest of APAC
  • Europe: The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
  • Rest of World: Latin America & the Middle East and Africa

The GERD Drug and devices market in North America is expected to hold the largest share by 2027 possibilities of the presence of a large patient population suffering from heartburn and the availability of OTC generics. The rise in the incidence of GERD in North America is responsible for the increase in demand for acid reducing and neutralizing drugs. Also, the self-medication trend for management of digestive and gastrointestinal disorders has become popular, owing to convenience, time saved and cost-effectiveness. On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the GERD Drug and devices market. The GERD market in Asia-Pacific is expected to grow at a justly high growth ratio as compared to other local markets due to the augmented acceptance of generic antacids and OTC along with the growing occurrence of heartburn.

The major market players of the global GERD Drug and devices market are:

  • ASTRAZENECA
  • EISAI INC
  • NOVARTIS
  • PFIZER, INC.
  • TAKEDA PHARMACEUTICALS COMPANY LIMITED

Company Profiles covers analysis of important players.

AstraZeneca PLC (AstraZeneca or ‘the company’) is involved in discovery, development, manufacturing, and marketing of prescription pharmaceuticals and biological products in the therapeutic areas of cardiovascular, gastrointestinal, infection, neuroscience, oncology and respiratory. Takeda Pharmaceutical Company Limited (Takeda or ‘the company’), a leading pharmaceutical company in Japan, is engaged in the research, development, manufacture, and marketing of pharmaceutical products. The company develops new drug products in its 19 research and development sites and 19 production sites in 18 countries and regions worldwide.

Key Findings of the Global GERD Drug and devices market:

  • Antacids drug class holds the largest market share
  • Bravo system devices are widely used
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • ANTACIDS DRUG CLASS HOLDS THE LARGEST MARKET SHARE
      • BRAVO SYSTEM DEVICES ARE WIDELY USED
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING TREND OF SELF-MEDICATION
      • INCREASING AWARENESS ABOUT GERD
      • INCREASING OCCURRENCE OF GERD DISORDERS
      • CHANGES IN LIFESTYLE
    • MARKET RESTRAINTS
      • PATENT EXPIRY
      • ADVERSE EFFECT OF PROTON PUMP INHIBITORS AND OTHER DRUGS
      • PROTON PUMP INHIBITOR RESISTANCE
    • MARKET OPPORTUNITIES
      • INCREASED PRACTICE OF GENERICS AND OTC DRUGS
      • COST-EFFECTIVE OTC DRUGS
      • OVERUSE OF MEDICATION AND DIETARY SUPPLEMENTS
    • MARKET CHALLENGES
      • USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS
      • PROBABILITY OF BUYING COUNTERFEIT DRUGS
    • MARKET BY DRUGS DOSAGE FORM
    • MARKET BY ROUTE OF ADMINISTRATION OF DRUGS
  2. MARKET BY DRUGS AND DEVICES
    • DRUG CLASS
      • ANTACIDS
      • H2 RECEPTOR BLOCKERS
        • CIMETIDINE
        • FAMOTIDINE
        • NIZATIDINE
        • RANITIDINE HCL
      • PROTON PUMP INHIBITORS (PPI)
        • NEXIUM
        • PRILOSEC/ LOSEC
        • ACIPHEX/ PARIET
        • DEXILANT
        • PROTONIX
        • PREVACID
        • ZEGERID
        • OTHER GENERIC PPI
      • PRO-KINETIC AGENTS
    • DEVICES
      • DIGITRAPPER
      • BRAVO SYSTEM
      • STRETTA
      • LINX REFLUX MANAGEMENT SYSTEM
      • MUSE (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM
      • OTHER DEVICES
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • PIPELINE DRUGS
    • REGULATORY FRAMEWORK
    • PATENT ANALYSIS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ASTRAZENECA
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BAUSCH HEALTH (FORMERLY VALEANT PHARMACEUTICALS INTERNATIONAL, INC.)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BOSTON SCIENTIFIC CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CEMPRA INC. (MERGED WITH MELINTA)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DAEWOONG CO. LTD.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • EISAI INC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • IRONWOOD PHARMACEUTICALS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JOHNSON & JOHNSON
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MERCK & CO., INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NOVARTIS
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • RAQUAL IA PHARMA INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • TAKEDA PHARMACEUTICALS COMPANY LIMITED
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1       GLOBAL GERD DRUGS AND DEVICES MARKET BY REGION 2019-2029 ($ MILLION)

TABLE 2       GLOBAL GERD DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 3       GLOBAL DRUG CLASS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 4       GLOBAL DRUG CLASS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5       GLOBAL ANTACIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6       GLOBAL H2 RECEPTOR BLOCKERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7       GLOBAL H2 RECEPTOR BLOCKERS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 8       GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9       GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 10     GLOBAL PRO-KINETIC AGENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11     GLOBAL DEVICES MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 12     GLOBAL DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13     GLOBAL DIGITRAPPER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14     GLOBAL BRAVO SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15     GLOBAL STRETTA (MEDERITHERAPEUTICS) MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16     GLOBAL LINX® REFLUX MANAGEMENT SYSTEM (TORAX MEDICAL) MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17     GLOBAL MUSE™ (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18     GLOBAL OTHER DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19     GLOBAL GERD DRUGS AND DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 20     NORTH AMERICA GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 21     EUROPE GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 22     ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 23     REST OF THE WORLD GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1     GLOBAL GERD DRUGS AND DEVICES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

FIGURE 2     GLOBAL GERD DRUGS AND DEVICES MARKET SHARE BY DRUGS AND DEVICES 2017 & 2027 (%)

FIGURE 3     GLOBAL H2 RECEPTOR BLOCKERS MARKET BY CIMETIDINE 2019-2027 ($ MILLION)

FIGURE 4     GLOBAL H2 RECEPTOR BLOCKERS MARKET BY FAMOTIDINE 2019-2027 ($ MILLION)

FIGURE 5     GLOBAL H2 RECEPTOR BLOCKERS MARKET BY NIZATIDINE 2019-2027 ($ MILLION)

FIGURE 6     GLOBAL H2 RECEPTOR BLOCKERS MARKET BY RANITIDINE HCL 2019-2027 ($ MILLION)

FIGURE 7     GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY NEXIUM 2019-2027 ($ MILLION)

FIGURE 8     GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY PRILOSEC/ LOSEC 2019-2027 ($ MILLION)

FIGURE 9     GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY ACIPHEX/ PARIET 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY DEXILANT 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY PROTONIX 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY PREVACID 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY ZEGERID 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL PROTON PUMP INHIBITORS (PPI) MARKET BY OTHER GENERIC PPI 2019-2027 ($ MILLION)

FIGURE 15   PORTER’S FIVE FORCE MODEL

FIGURE 16   GLOBAL GERD DRUGS AND DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 17   THE UNITED STATES GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 18   CANADA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 19   THE UNITED KINGDOM GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 20   GERMANY GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 21   FRANCE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 22   ITALY GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 23   SPAIN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 24   REST OF EUROPE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 25   JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 26   CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 27   INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 28   AUSTRALIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 29   SOUTH KOREA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 30   REST OF ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 31   LATIN AMERICA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 32   MIDDLE EAST AND AFRICA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 33   GERD PPIS DRUGS PROVIDER COMPANY MARKET SHARE 2017 (%)

  1. MARKET BY DRUGS AND DEVICES
    • DRUG CLASS
      • ANTACIDS
      • H2 RECEPTOR BLOCKERS
        • CIMETIDINE
        • FAMOTIDINE
        • NIZATIDINE
        • RANITIDINE HCL
      • PROTON PUMP INHIBITORS (PPI)
        • NEXIUM
        • PRILOSEC/ LOSEC
        • ACIPHEX/ PARIET
        • DEXILANT
        • PROTONIX
        • PREVACID
        • ZEGERID
        • OTHER GENERIC PPI
      • PRO-KINETIC AGENTS
    • DEVICES
      • DIGITRAPPER
      • BRAVO SYSTEM
      • STRETTA
      • LINX REFLUX MANAGEMENT SYSTEM
      • MUSE (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM
      • OTHER DEVICES
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now